4ypg

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (08:03, 27 September 2023) (edit) (undo)
 
(2 intermediate revisions not shown.)
Line 1: Line 1:
==Structural Insights Into the Neutralization Properties of a Human Anti-Interferon Monoclonal Antibody==
==Structural Insights Into the Neutralization Properties of a Human Anti-Interferon Monoclonal Antibody==
-
<StructureSection load='4ypg' size='340' side='right' caption='[[4ypg]], [[Resolution|resolution]] 3.00&Aring;' scene=''>
+
<StructureSection load='4ypg' size='340' side='right'caption='[[4ypg]], [[Resolution|resolution]] 3.00&Aring;' scene=''>
== Structural highlights ==
== Structural highlights ==
-
<table><tr><td colspan='2'>[[4ypg]] is a 6 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4YPG OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4YPG FirstGlance]. <br>
+
<table><tr><td colspan='2'>[[4ypg]] is a 6 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4YPG OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4YPG FirstGlance]. <br>
-
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=NI:NICKEL+(II)+ION'>NI</scene></td></tr>
+
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 3&#8491;</td></tr>
-
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4ypg FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4ypg OCA], [http://pdbe.org/4ypg PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4ypg RCSB], [http://www.ebi.ac.uk/pdbsum/4ypg PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=4ypg ProSAT]</span></td></tr>
+
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=NI:NICKEL+(II)+ION'>NI</scene></td></tr>
 +
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4ypg FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4ypg OCA], [https://pdbe.org/4ypg PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4ypg RCSB], [https://www.ebi.ac.uk/pdbsum/4ypg PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4ypg ProSAT]</span></td></tr>
</table>
</table>
== Function ==
== Function ==
-
[[http://www.uniprot.org/uniprot/IFNA2_HUMAN IFNA2_HUMAN]] Produced by macrophages, IFN-alpha have antiviral activities.
+
[https://www.uniprot.org/uniprot/Q6PJF2_HUMAN Q6PJF2_HUMAN]
<div style="background-color:#fffaf0;">
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
== Publication Abstract from PubMed ==
Line 18: Line 19:
</div>
</div>
<div class="pdbe-citations 4ypg" style="background-color:#fffaf0;"></div>
<div class="pdbe-citations 4ypg" style="background-color:#fffaf0;"></div>
 +
 +
==See Also==
 +
*[[Interferon 3D structures|Interferon 3D structures]]
 +
*[[Monoclonal Antibodies 3D structures|Monoclonal Antibodies 3D structures]]
== References ==
== References ==
<references/>
<references/>
__TOC__
__TOC__
</StructureSection>
</StructureSection>
-
[[Category: Acqua, W F.Dall]]
+
[[Category: Homo sapiens]]
-
[[Category: Oganesyan, V]]
+
[[Category: Large Structures]]
-
[[Category: Ifn-alpha2a]]
+
[[Category: Dall'Acqua WF]]
-
[[Category: Therapeutic mab]]
+
[[Category: Oganesyan V]]

Current revision

Structural Insights Into the Neutralization Properties of a Human Anti-Interferon Monoclonal Antibody

PDB ID 4ypg

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Personal tools